OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
18
Results
Show all
Save search
Copy query
Show results for
Unknown
(18)
Publication Date
Release Date
2021
(6)
2020
(4)
2024
(2)
2011
(2)
2022
(1)
2019
(1)
2016
(1)
2013
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic.
Not available
S-EPMC7237184
|
biostudies-literature
Cite
Human Conjunctival Transcriptome in Acanthamoeba Keratitis: An Exploratory Study.
Not available
S-EPMC11371541
|
biostudies-literature
Cite
A behavioural approach to specifying interventions: what insights can be gained for the reporting and implementation of interventions to reduce antibiotic use in hospitals?
Not available
S-EPMC7177472
|
biostudies-literature
Cite
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Not available
S-EPMC11249957
|
biostudies-literature
Cite
Proteogenomic characterization of pancreatic ductal adenocarcinoma.
Not available
S-EPMC8654574
|
biostudies-literature
Cite
The CAFA challenge reports improved protein function prediction and new functional annotations for hundreds of genes through experimental screens.
Not available
S-EPMC6864930
|
biostudies-literature
Cite
A proteogenomic portrait of lung squamous cell carcinoma.
Not available
S-EPMC8475722
|
biostudies-literature
Cite
Mapping the human genetic architecture of COVID-19.
Not available
S-EPMC8674144
|
biostudies-literature
Cite
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.
Not available
S-EPMC7946781
|
biostudies-literature
Cite
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.
Not available
S-EPMC7373300
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets